Literature DB >> 9477772

Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.

D J Robinson1, H S de Bruijn, N van der Veen, M R Stringer, S B Brown, W M Star.   

Abstract

The photobleaching of 5-aminolaevulinic acid (ALA)-induced protoporphyrin IX (PpIX) was investigated during superficial photodynamic therapy (PDT) in normal skin of the SKH HR1 hairless mouse. The effects of light dose and fluence rate on the dynamics and magnitude of photobleaching and on the corresponding PDT-induced damage were examined. The results show that the PDT damage cannot be predicted by the total light dose. Photobleaching was monitored over a wide range of initial PpIX fluorescence intensities. The rate of PpIX photobleaching is not a simple function of fluence rate but is dependent on the initial concentration of sensitizer. Also, at high fluence rates (50-150 mW/cm2, 514 nm) oxygen depletion is shown to have a significant effect. The rate of photobleaching with respect to light dose and the corresponding PDT damage both increase with decreasing fluence rate. We therefore suggest that the definition of a bleaching dose as the light dose that causes a 1/e reduction in fluorescence signal is insufficient to describe the dynamics of photobleaching and PDT-induced damage. We have detected the formation of PpIX photoproducts during the initial period of irradiation that were themselves subsequently photobleached. In the absence of oxygen, PpIX and its photoproducts are not photobleached. We present a method of calculating a therapeutic dose delivered during superficial PDT that demonstrates a strong correlation with PDT damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477772

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  46 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

3.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2004-10-26       Impact factor: 3.161

4.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2005       Impact factor: 3.161

5.  Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy.

Authors:  Asta Juzeniene; Petras Juzenas; Li-Wei Ma; Vladimir Iani; Johan Moan
Journal:  Lasers Med Sci       Date:  2004-10-16       Impact factor: 3.161

Review 6.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

7.  Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy.

Authors:  Shannon M Gallagher-Colombo; Harry Quon; Kelly M Malloy; Peter H Ahn; Keith A Cengel; Charles B Simone; Ara A Chalian; Bert W O'Malley; Gregory S Weinstein; Timothy C Zhu; Mary E Putt; Jarod C Finlay; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2015-07-02       Impact factor: 3.421

8.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

9.  Macroscopic singlet oxygen model incorporating photobleaching as an input parameter.

Authors:  Michele M Kim; Jarod C Finlay; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-02

10.  Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.

Authors:  Hiral Patel; Rosemarie Mick; Jarod Finlay; Timothy C Zhu; Elizabeth Rickter; Keith A Cengel; S Bruce Malkowicz; Stephen M Hahn; Theresa M Busch
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.